MINI REVIEW article
Front. Nat. Prod.
Sec. Biological Activities of Natural Products
This article is part of the Research TopicBridging Traditional and Modern Medicine: The Role of Botanicals in HealthcareView all 9 articles
Bridging Eras: Integrating Ancient Remedies with Modern Biotechnology to Combat Non-TB Skin Infections
Provisionally accepted
Kinjal Upadhyay1*
Nisarg Kumar Teli2- 1Department of Biochemistry and Biotechnology, St. Xavier's college, Ahmedabad, India, Ahmedabad, India
- 2Gujarat Biotechnology University, Gandhinagar, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The rising global concern of antibiotic resistance has renewed scientific interest in understanding and exploring the traditional remedies as alternative or complementary therapeutics. Ancient medical systems such as Ayurveda have used plant-based systems such as Neem, turmeric for their anti-inflammatory, antimicrobial and/or wound healing actions. Non-tuberculosis mycobacteria (NTM), a diverse group of mycobacterial species excluding Mycobacterium tuberculosis, are increasingly recognised as important causes of chronic skin and soft tissue infections. These infections are specifically challenging as the NTM species often invade deeper layers of the skin, exhibiting high levels of intrinsic antibiotic resistance and are frequently difficult to diagnose in early stages of infections. As a result of this, treatment failures are often, and hence there is a growing interest in sustainable, natural and less toxic treatment options. This leads to the need for scientifically backed ancient knowledge as a potential solution for these kinds of infections. Modern biotechnology could provide innovative ways to enhance the clinical utility of such natural or ancient compounds by addressing limitations, like poor solubility, low stability and restricted tissue penetration. Modern biotechnology could enhance bioavailability and allow controlled as well as targeted release at infected sites. Therefore, the integration of traditional or ancient plant-derived therapeutics with advanced biotechnology holds a significant promise for developing safer, more effective and sustainable treatment approaches against NTM-related skin infections. The upcoming part focuses on bridging ancient remedies with modern biotechnology for their combined potential advantages and real-life applications, with regard to the management of non-TB mycobacterial skin infections.[NT1][NT2]
Keywords: early diagnosis, Non-tuberculosis mycobacteria, Skin infections, Soft Tissue Infections, Treatment
Received: 14 Aug 2025; Accepted: 01 Dec 2025.
Copyright: © 2025 Upadhyay and Kumar Teli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Kinjal Upadhyay
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.